The Chinese government announced Wednesday it had concluded its corruption investigation into British pharmaceutical giant GlaxoSmithKline plc and would be charging three former executives, including the company’s head of China operations and its legal director.
According to the official Xinhua news agency, the 10-month probe was conducted by officers of the Public Security Bureau based in Changsha, a city in Hunan province in central China. The three executives were detained last year as the government investigated charges that they led a bribery campaign targeting doctors, hospitals and officials to prescribe or purchase GSK products.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
